Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
(NASDAQ: ARVN) Delayed: 8.14 +0.40 (5.17%)
Previous Close $7.74    52 Week High $ 
Open $7.63    52 Week Low $ 
Day High $8.19    P/E N/A 
Day Low $7.63    EPS $ 
Volume 852,154       

(NASDAQ: ARVN) Delayed: 8.14 +0.40 (5.17%)
Previous Close $7.74    52 Week High $ 
Open $7.63    52 Week Low $ 
Day High $8.19    P/E N/A 
Day Low $7.63    EPS $ 
Volume 852,154